More adults with IgE-mediated peanut allergy receiving remibrutinib vs. placebo for 4 weeks tolerated a single dose of at least 600 mg peanut protein without dose-limiting symptoms, according to a ...
Parents across the U.S. are introducing peanut products to their infants earlier than ever, following guidelines that the ...
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections ...
New research shows gut microbiota can metabolise peanut allergens and reduce IgE-mediated anaphylaxis severity. Learn more.
People with severe peanut allergies produce large amounts of immunoglobulin E (IgE) antibodies when exposed to peanut proteins, including two called Ara h 1 and 2. This leads to an inflammation ...
Children with shellfish allergy had reduced odds for outgrowing this allergy if they also had asthma, oral allergy syndrome ...
Whereas natural tolerance rates are generally high for common allergens, such as eggs, milk, and wheat, allergies to other foods often persist beyond childhood. For instance, approximately 72.2% of ...
PHB-050 is currently in a Phase 1 clinical trial for food allergy. The ongoing trial is expected to generate key data on safety, pharmacokinetics and the potential to rapidly reduce circulating IgE ...
A wearable device that alerts people with food allergies before a reaction begins has the potential to reduce ...
It is estimated that around 10% of the US population has peanut allergies, a medical emergency that can be treated but not cured. Compared to those without allergies, these individuals are at a ...
Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such as anaphylaxis, asthma, food allergy, and allergic rhinitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results